It’s hard even for a healthcare insider to navigate the system, let alone appeal a denial with amorphous reasoning behind it.
Related stories
AMD to buy Fei-Fei Li’s AI start-up for $8bn
Bond yields move relentlessly higher, as Wall Street wonders how much more tech stocks can take
Before you invest in the Oura IPO, understand what you’re buying
October is historically the most volatile month for stocks. But why? These 4 popular theories fail to hold up.
PepsiCo plans to raise prices on sodas, chips and dip — and that has Wall Street worried
Dolly Parton planned for her estate. The fight with her nephew shows why that matters.